第一单位：
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.;Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
作者：
Barrie,Peck [1]
;
Philip,Bland [1]
;
Ioanna,Mavrommati [1]
;
Gareth,Muirhead [2]
;
Hannah,Cottom [1]
;
Patty T,Wai [1]
;
Sarah L,Maguire [3]
;
Holly E,Barker [4]
;
Eamonn,Morrison [2]
;
Divya,Kriplani [2]
;
Lu,Yu [5]
;
Amy,Gibson [1]
;
Giulia,Falgari [1]
;
Keith,Brennan [6]
;
Gillian,Farnie [7]
;
Richard,Buus [2]
;
Rebecca,Marlow [8]
;
Daniela,Novo [2]
;
Eleanor,Knight [2]
;
Naomi,Guppy [2]
;
Daniela,Kolarevic [9]
;
Snezana,Susnjar [10]
;
Natasa Medic,Milijic [11]
;
Kalnisha,Naidoo [2]
;
Patrycja,Gazinska [2]
;
Ioannis,Roxanis [2]
;
Sunil,Pancholi [2]
;
Lesley-Ann,Martin [2]
;
Erle M,Holgersen [2]
;
Maggie C U,Cheang [12]
;
Farzana,Noor [2]
;
Sophie,Postel-Vinay [13]
;
Gerard,Quinn [14]
;
Simon,McDade [14]
;
Lukas,Krasny [15]
;
Paul,Huang [15]
;
Frances,Daley [2]
;
Fredrik,Wallberg [2]
;
Jyoti S,Choudhary [5]
;
Syed,Haider [2]
;
Andrew N,Tutt [8]
;
Rachael,Natrajan [16]
作者单位：
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.;Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
[1]
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
[2]
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.;Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
[3]
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.;Division of Stem Cells and Cancer, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
[4]
Division of Cancer Biology, The Institute of Cancer Research, London, England, United Kingdom.
[5]
Faculty of Life Sciences, University of Manchester, Manchester, England, United Kingdom.
[6]
SGC Oxford, University of Oxford, Oxford, England, United Kingdom.
[7]
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.;Breast Cancer Now Research Unit, King's College London, London, England, United Kingdom.
[8]
The Royal Marsden NHS Foundation Trust, London, England, United Kingdom.
[9]
Department of Medical Oncology, The Institute of Oncology and Radiology of Serbia, Belgrade, Serbia.
[10]
Department of Pathology and Cytology, The Institute of Oncology and Radiology of Serbia, Belgrade, Serbia.
[11]
Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, England, United Kingdom.
[12]
Department of Drug Development (DITEP), Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.;UMR981, ATIP-Avenir team, INSERM, Villejuif, France.
[13]
Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
[14]
Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
[15]
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom. rachael.natrajan@icr.ac.uk.;Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
[16]
DOI
10.1158/0008-5472.CAN-20-1822
PMID
33509944
发布时间
2025-05-30
换一批
